466 related articles for article (PubMed ID: 15884408)
1. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
[TBL] [Abstract][Full Text] [Related]
2. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
4. [Whooping cough in The Netherlands, 1989-1994].
de Melker HE; Conyn-van Spaendonck MA; Rümke HC; Sprenger MJ; Schellekens JF
Ned Tijdschr Geneeskd; 1995 Jun; 139(25):1280-6. PubMed ID: 7609803
[TBL] [Abstract][Full Text] [Related]
5. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
[TBL] [Abstract][Full Text] [Related]
6. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
[TBL] [Abstract][Full Text] [Related]
7. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
8. [Pertussis in the Netherlands].
de Greeff SC; de Melker HE; Mooi FR
Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
[TBL] [Abstract][Full Text] [Related]
9. Effect of the preschool pertussis booster on national notifications of disease in Australia.
Torvaldsen S; McIntyre PB
Pediatr Infect Dis J; 2003 Nov; 22(11):956-9. PubMed ID: 14614366
[TBL] [Abstract][Full Text] [Related]
10. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
Matter HC; Schmidt-Schläpfer G; Zimmermann H
Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
[TBL] [Abstract][Full Text] [Related]
12. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
13. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
14. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
[TBL] [Abstract][Full Text] [Related]
15. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
16. [Pertussis: a reemerging infection?].
Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
[TBL] [Abstract][Full Text] [Related]
17. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology.
Blakely T; Mansoor O; Baker M
N Z Med J; 1999 Feb; 112(1081):30-3. PubMed ID: 10078212
[TBL] [Abstract][Full Text] [Related]
18. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
[TBL] [Abstract][Full Text] [Related]
19. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
20. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
Kimura M; Kuno-Sakai H
Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
